These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7433060

  • 21. [Sequelae of combined toxoplasmosis therapy in childhood].
    Weiland R, Otto FM.
    Dtsch Gesundheitsw; 1968 May 02; 23(18):830-5. PubMed ID: 5680323
    [No Abstract] [Full Text] [Related]

  • 22. [Various data on the treatment of toxoplasmosis with chloridin].
    Zabugin FD.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968 May 02; 67(8):1130. PubMed ID: 5680516
    [No Abstract] [Full Text] [Related]

  • 23. [Hemopoietic disorders under effect of chloridin].
    Zelenyĭ IM.
    Probl Gematol Pereliv Krovi; 1968 Apr 02; 13(4):58-9. PubMed ID: 5736527
    [No Abstract] [Full Text] [Related]

  • 24. [What is necessary to know in order to understand the serology of toxoplasmosis and to make a therapeutic decision].
    Benzecry E.
    Prensa Med Argent; 1971 Dec 31; 58(4):2107-22. PubMed ID: 5140329
    [No Abstract] [Full Text] [Related]

  • 25. [Side effects of toxoplasmosis treatment].
    Deroń Z, Jabłkowski M.
    Pol Tyg Lek; 1980 Jun 09; 35(23):857-9. PubMed ID: 6447863
    [No Abstract] [Full Text] [Related]

  • 26. [The effect of chloridin on the blood of pregnant women].
    Shitova EM.
    Probl Gematol Pereliv Krovi; 1966 Jan 09; 11(1):25-7. PubMed ID: 5985101
    [No Abstract] [Full Text] [Related]

  • 27. Hyperpigmentation due to pyrimethamine use.
    Ozturk R, Engin A, Ozaras R, Mert A, Tabak F, Aktuğlu Y.
    J Dermatol; 2002 Jul 09; 29(7):443-5. PubMed ID: 12184645
    [Abstract] [Full Text] [Related]

  • 28. Notes on the treatment of toxoplasmosis.
    Kouba K, Nevarilová A, Sixtová E, Tichý V, Lasovská J.
    Acta Univ Carol Med (Praha); 1974 Jul 09; 20(1-2):67-88. PubMed ID: 4455074
    [No Abstract] [Full Text] [Related]

  • 29. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.
    Foot AB, Garin YJ, Ribaud P, Devergie A, Derouin F, Gluckman E.
    Bone Marrow Transplant; 1994 Aug 09; 14(2):241-5. PubMed ID: 7994239
    [Abstract] [Full Text] [Related]

  • 30. Problems of hematopoesis in the treatment of toxoplasmosis.
    Kouba K, Nevarilová A, Lasovská J, Josífko M, Hübner J.
    Acta Univ Carol Med (Praha); 1974 Aug 09; 20(1-2):105-19. PubMed ID: 4455068
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Skin manifestations in toxoplasmosis.
    Andreev VC, Angelov N, Zlatkov NB.
    Arch Dermatol; 1969 Aug 09; 100(2):196-9. PubMed ID: 5797961
    [No Abstract] [Full Text] [Related]

  • 34. [Complex treatment of chronic acquired toxoplasmosis with antireticular cytotoxic serum, chloridin and sulfadimezine].
    Averina NI.
    Vrach Delo; 1969 Mar 09; 3():106-9. PubMed ID: 5369639
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Parahilar lymphadenopathy due to toxoplasmosis].
    Jesiotr M.
    Harefuah; 1971 Aug 15; 81(4):184-5. PubMed ID: 5160520
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.